Hyderabad-based VINS Bioproducts gets DCGI nod to start clinical trials for VINCOV-19
Hyderabad: VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and